MedTrace Logo

iCare HOME2 Clinical Trial

NCT05162989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2021-12-20

No results posted yet for this study

Summary

The aim of this clinical study is to provide information about the variability of the intraocular pressure (IOP) self-measurements with the iCare HOME2 tonometer in comparison to the variability of the IOP measurements with the reference tonometer (iCare IC200), over a wide range of IOP values.

Conditions

Interventions

DEVICE

iCare HOME2 vs iCare IC200

Measurement of IOP with iCare HOME2 compared with iCare IC200.

Sponsors & Collaborators

  • Icare Finland Oy

    lead INDUSTRY

Principal Investigators

  • Michelle A Sato, MD · East West Eye Institute

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-26
Primary Completion
2021-12-15
Completion
2021-12-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05162989 on ClinicalTrials.gov